Vieri Scotti
0000-0002-1498-7171
2 papers found
Refreshing results…
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Missing publications? Search for publications with a matching author name.